In the race to develop a potential vaccine for coronavirus, Oxford’s COVID-19 vaccine is at the forefront. Meanwhile, according to the reports, a volunteer in Brazil has died in the third-stage trial of the COVID-19. Officials gave this information on Wednesday. However, media reports state that the deceased volunteer hadn’t received the vaccine’s shot. Brazilian health authority Anvisa said on Wednesday that a volunteer has died in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford.
Oxford has confirmed plans to continue the trials:
Oxford has confirmed plans to continue the trials. It also issued a statement saying that after careful evaluation there is nothing to worry about the safety of the clinical trial. AstraZeneca declined to comment immediately on the matter.
A source familiar with the matter said that if the volunteer who died had been given the COVID-19 vaccine, the trial would have been suspended. They reported that the person was part of the control group that was given the drug for meningitis.
Federal University of Sao Paulo helping coordinate Phase III clinical trials in Brazil:
The Federal University of Sao Paulo is helping to coordinate Phase III clinical trials in Brazil. University said an independent review committee had also recommended the continuation of the trial. The university didn’t provide personal information about the volunteer.
“Everything is proceeding as expected, without any cases of serious vaccine-related complications in any participating volunteer,” the University of Brazil said in a statement.
10,000 volunteers included in the trial: Federal University
A university spokesman said that of the 10,000 volunteers included in the trial. 8,000 volunteers have received the first dose of the vaccine in 6 Brazilian cities, and many of them have already been given the second dose.
According to the latest update from John Hopkins University, there have been 5,273,954 cases of Covid-19 in Brazil. While 154,837 people have died so far from this deadly virus. Brazil is the third most affected country in the world after the US and India.